Gallacher Capital Management LLC Cassava Sciences Inc Transaction History
Gallacher Capital Management LLC
- $216 Billion
- Q2 2025
A detailed history of Gallacher Capital Management LLC transactions in Cassava Sciences Inc stock. As of the latest transaction made, Gallacher Capital Management LLC holds 64,975 shares of SAVA stock, worth $142,295. This represents 0.05% of its overall portfolio holdings.
Number of Shares
64,975
Previous 69,660
6.73%
Holding current value
$142,295
Previous $104 Million
12.55%
% of portfolio
0.05%
Previous 0.05%
Shares
11 transactions
Others Institutions Holding SAVA
# of Institutions
155Shares Held
15.7MCall Options Held
1.67MPut Options Held
1.26M-
Black Rock Inc. New York, NY3.22MShares$7.05 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.44MShares$5.35 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.03MShares$2.25 Million0.0% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny909KShares$1.99 Million0.0% of portfolio
-
State Street Corp Boston, MA874KShares$1.91 Million0.0% of portfolio
About CASSAVA SCIENCES INC
- Ticker SAVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,097,900
- Market Cap $87.8M
- Description
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...